ThinkEquity Initiates Coverage on Beckman Coulter (BEC) with an Accumulate
More News related to BEC
- BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
- Beckman Coulter to Present at the 2009 Piper Jaffray Healthcare Conference
- Beckman Coulter (BEC) Tops Q3 EPS by 1c; Ups FY EPS Views
- Beckman Coulter Announces Third Quarter 2009 Results
- Beckman Coulter Announces Conference Call and Webcast of Accompanying Slides in Conjunction With Third Quarter 2009 Earnings
More News related to New Coverage
- Deutsche Bank Starts Coverage on Utilities Stocks: CMS, AEP, EIX, ITC, PSEG at Buy
- Keefe, Bruyette and Woods Initiates Coverage of Taubman Centers (TCO) with an Outperform
- Keefe, Bruyette and Woods Initiates Coverage of Simon Property Group (SPG) with an Outperform
- Keefe, Bruyette and Woods Initiates Coverage of Tanger Factory Outlet Centers (SKT) with a Market Perform
- Keefe, Bruyette and Woods Initiates Coverage of Pennsylvania REIT (PEI) with a Market Perform
ThinkEquity initiates coverage on Beckman Coulter (NYSE: BEC) with an Accumulate rating. Price target $60.
To see more analyst ratings on BEC Click Here.
Beckman Coulter, Inc. is a manufacturer and marketer of biomedical testing instrument systems, tests and supplies.
Related Categories
New CoverageStocks Mentioned
+0.97Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
